Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2026-01-08 00:00:00 ET · period of report 2026-01-06 · accession 0001239648-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-08 | 2026-01-07 | ANAB | LOUMEAU ERIC J | CLO | S - Sale+OE | $45.56 | -9,639 | 9,657 | -50% | -$439.2K |
| D | 2026-01-08 | 2026-01-06 | ANAB | LOUMEAU ERIC J | CLO | M - OptEx | — | +5,545 | 18.8K | +42% | — |
| DM | 2026-01-08 | 2026-01-06 | ANAB | LOUMEAU ERIC J | CLO | A - Grant | $0.00 | +40.3K | 23.2K | New | $0 |
| D | 2026-01-08 | 2026-01-06 | ANAB | LOUMEAU ERIC J | CLO | M - OptEx | $0.00 | -5,545 | 5,545 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-07 | S | D | 2,017 | $45.11 | 16,779 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-07 | S | D | 5,281 | $45.38 | 11,498 | D | — | — | (F4) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.87 to $45.835 per share, inclusive. The reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2026-01-06 | M | A | 5,545 | — | 18,796 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
| 4 | Common | Common Stock | 2026-01-07 | S | D | 500 | $47.23 | 9,157 | D | — | — | |
| 5 | Common | Common Stock | 2026-01-07 | S | D | 1,841 | $46.13 | 9,657 | D | — | — | (F5) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.96 to $46.83 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 6 | Derivative | Restricted Stock Unit | 2026-01-06 | A | A | 17,100 | $0.00 | 17,100 | D | — · — to — | 17,100 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F7) The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| 7 | Derivative | Restricted Stock Unit | 2026-01-06 | M | D | 5,545 | $0.00 | 5,545 | D | — · — to — | 5,545 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F6) The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| 8 | Derivative | Stock Option (right to buy) | 2026-01-06 | A | A | 23,200 | $0.00 | 23,200 | D | $43.91 · — to 2036-01-05 | 23,200 Common Stock | (F8) The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |